- Home
- GRX vs ACHV Comparison
GRX vs ACHV Comparison
Compare GRX & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- ACHV
- Stock Information
- Founded
- GRX 2007
- ACHV N/A
- Country
- GRX United States
- ACHV United States
- Employees
- GRX N/A
- ACHV N/A
- Industry
- GRX Finance/Investors Services
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GRX Finance
- ACHV Health Care
- Exchange
- GRX Nasdaq
- ACHV Nasdaq
- Market Cap
- GRX 142.7M
- ACHV 167.6M
- IPO Year
- GRX N/A
- ACHV N/A
- Fundamental
- Price
- GRX $9.23
- ACHV $4.80
- Analyst Decision
- GRX
- ACHV Strong Buy
- Analyst Count
- GRX 0
- ACHV 1
- Target Price
- GRX N/A
- ACHV $12.00
- AVG Volume (30 Days)
- GRX 39.7K
- ACHV 2.4M
- Earning Date
- GRX 01-01-0001
- ACHV 11-06-2025
- Dividend Yield
- GRX 5.98%
- ACHV N/A
- EPS Growth
- GRX N/A
- ACHV N/A
- EPS
- GRX 0.26
- ACHV N/A
- Revenue
- GRX N/A
- ACHV N/A
- Revenue This Year
- GRX N/A
- ACHV N/A
- Revenue Next Year
- GRX N/A
- ACHV N/A
- P/E Ratio
- GRX $38.50
- ACHV N/A
- Revenue Growth
- GRX N/A
- ACHV N/A
- 52 Week Low
- GRX $7.73
- ACHV $1.84
- 52 Week High
- GRX $10.40
- ACHV $5.78
- Technical
- Relative Strength Index (RSI)
- GRX 48.46
- ACHV 68.63
- Support Level
- GRX $9.23
- ACHV $4.65
- Resistance Level
- GRX $9.34
- ACHV $5.07
- Average True Range (ATR)
- GRX 0.10
- ACHV 0.36
- MACD
- GRX 0.01
- ACHV 0.07
- Stochastic Oscillator
- GRX 46.61
- ACHV 67.45
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.